Etiometry

Etiometry is a leader in clinical decision-support software designed for intensive care units (ICUs). The company's platform provides valuable insights and analysis to support early recognition of subtle changes in patients' conditions, helping avoid complications and expediting recovery. Etiometry's technology leverages artificial intelligence (AI) and risk analytics to continuously interpret patient-generated data from various sources, including vital signs, lab results, and medical devices. This enables individualized risk assessments and alerts for potential deterioration.

The platform's key features include data aggregation and visualization, presenting a holistic view of patient information on a single screen. Its FDA-cleared risk algorithms, such as the IDO2, IVCO2, HLA, and ACD indices, track fundamental pathways of patient deterioration, providing early warning signs. Additionally, Etiometry's clinical pathway automation capabilities embed hospital-specific guidelines to standardize workflows and drive timely protocol adherence.

Furthermore, Etiometry's Quality Improvement Application offers a normalized database with over 150 million hours of de-identified patient data, facilitating continuous improvements and clinical research. In 2022, the company expanded its FDA-cleared risk analytics portfolio, expanding its capabilities to serve more patient populations.

Etiometry's platform has demonstrated improved clinical outcomes, including decreased hospital lengths of stay, reduced ICU readmissions, and shorter durations on mechanical ventilation and invasive treatments. As of January 2023, the company's database exceeded 150 million hours of de-identified patient data signals.